Members of the resist TB team recently published an open access letter to the editor regarding the effectiveness of consilia. Please find the article here.
top of page
Recent Posts
See AllThis week, the WHO recommended four new treatments for patients with MDR-TB. Three of the regimens were from the End TB trial, and one...
90
The Health Justice Initiative in South Africa has reported that the South African government is utilizing the Competition Act to...
260
Johnson and Johnson successfully applied for a patent extension on bedaquiline; however, in a big win for LMI countries, the company has...
150
bottom of page
Comments